GoodRx Holdings

GoodRx Holdings

GDRX· Services· Fiscal year ends in December

CEO pay in FY2025Stock -41.7% in FY2025

Wendy Barnes is the CEO of GoodRx Holdings and was paid $23.4M in FY2025 (Dec).

Pay$100 in the stock at the end of FY24 → $58
CEO pay is from each GoodRx Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Wendy BarnesFY2025
  2. 2Christopher McGinnisFY2025
  3. 3Romin NabieyFY2025
  4. 4Trevor BezdekFY2025
  5. 5Scott WagnerFY2025
  6. 6Karsten VoermannFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

GoodRx Holdings paid its 6 named executives $35.4M in total in FY2025 (Dec). CEO Wendy Barnes was paid $23.4M of that.

Name
Wendy BarnesChief Executive Officer & PresidentNot disclosedNot disclosed
Christopher McGinnisChief Financial Officer & TreasurerNot disclosedNot disclosed
Romin NabieyChief Accounting Officer and Former Interim Chief Financial Officer
Trevor BezdekCo-Chairman of the BoardNot disclosed
Scott WagnerFormer Interim Chief Executive Officer
Karsten VoermannFormer Chief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers22

See all

The FY2025 (Dec) proxy of GoodRx Holdings names 22 peer companies for pay. Among GoodRx Holdings and these peers, CEO pay was the highest of 16 and total shareholder return was 15th highest of 16.

1st highest of 16in GoodRx Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$1$23.4M

15th highest of 16in GoodRx Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$4$222

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

  1. Pay
    GoodRx Holdings Chair pay rose 14% to $971.6K. The stock fell 42% in FY2025 (Dec).
    DEF 14A
  2. Pay
    GoodRx Holdings Chair pay fell 91% to $856.8K. The stock fell 42% in FY2025 (Dec).
    DEF 14A
  3. Pay
    GoodRx Holdings CAO pay rose 33% to $1.3M. The stock fell 42% in FY2025 (Dec).
    DEF 14A
  4. Pay
    GoodRx Holdings CAO pay rose 14% to $2.6M. The stock rose 44% in FY2023 (Dec).
    DEF 14A
  5. Pay
    GoodRx Holdings Former CFO pay fell 95% to $280.3K. The stock fell 42% in FY2025 (Dec).
    DEF 14A
  6. Pay
    GoodRx Holdings Former CFO pay fell 83% to $902.2K. The stock rose 44% in FY2023 (Dec).
    DEF 14A
  7. Pay
    GoodRx Holdings CAO pay fell 64% to $942.6K. The stock fell 31% in FY2024 (Dec).
    DEF 14A
  8. Pay
    GoodRx Holdings Former Chief Operating Officer pay fell 54% to $2.9M. The stock fell 31% in FY2024 (Dec).
    DEF 14A
  9. Pay
    GoodRx Holdings Former Chief Operating Officer pay fell 63% to $6.3M. The stock rose 44% in FY2023 (Dec).
    DEF 14A
  10. Pay
    GoodRx Holdings Former CFO pay rose 547% to $5.8M. The stock fell 31% in FY2024 (Dec).
    DEF 14A
  11. Pay
    GoodRx Holdings Former CFO pay rose 905% to $5.2M. The stock fell 86% in FY2022 (Dec).
    DEF 14A
  12. Pay
    GoodRx Holdings Director pay rose 55% to $784.9K. The stock rose 44% in FY2023 (Dec).
    DEF 14A
  13. Pay
    GoodRx Holdings Former President, Healthcare pay rose 860% to $4.9M. The stock rose 44% in FY2023 (Dec).
    DEF 14A
  14. Pay
    GoodRx Holdings Former President, Healthcare pay fell 41% to $512.0K. The stock fell 86% in FY2022 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 29, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 25, 2024FY2023
Annual report10-KFeb 29, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data